Navigation Links
Mirus Bio, Pfizer enter multimillion-dollar research agreement

Madison, Wis. - In an effort to address the lack of an effective delivery method in the emerging field of RNA interference, Mirus Bio Corp. has entered into a two-year, multimillion dollar agreement with Pfizer, Inc. to develop gene silencing methods in animal models.

Russell Smestad, president of Mirus Bio, said the lack of effective delivery methods has been an Achilles' heel tha......

Full article >>> om negotiating with others. "We anticipate leveraging this agreement into future opportunities as well," he said.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 01/09/07


Related biology technology :

1. Mirus Bio secures $900K grant to develop research tool
2. Mirus Bio awarded patent on RNA delivery
3. Mirus granted European patent for gene therapy
4. Mirus provides low-cost way to modify genes
5. Mirus announces new method for making antibodies
6. Platypus adds Mirus VP to board of directors
7. Mirus receives $1.26 million SBIR grant to combat anemia
8. Pfizer-Pharmacia Fallout Gives Celltech A CEO
9. NanoRite Innovation Center opens with small science, big promise
10. UW-Madison to receive $125M for bioenergy research center
11. WARF enters licensing agreements for stem cell products
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):